Table 2 Effects of the intervention for the different end-point examined
Baseline (mean, SD) | Follow-up (mean, SD) | Within group difference (mean, 95% CI) | p | |
|---|---|---|---|---|
Headache | ||||
Days with headache (mean) | 6.4 (8.14) | 4.58 (7.64) | −1.81 (−2.54, −1.09) | <0.0001 |
Among subjects with at least 4 days/month with headache at baseline | 12.49 (8.81) | 8.62 (9.65) | −3.87 (−5.20, −2.54) | <0.0001 |
Headache Index (F × I) | 0.45 (0.74) | 0.32 (0.67) | −0.13 (−0.19, −0.07) | 0.0001 |
Among subjects with at least 4 days/month with headache at baseline | 0.89 (0.92) | 0.60 (0.87) | −0.29 (−0.40, −0.18) | <0.0001 |
Neck/shoulder pain | ||||
Days with neck/shoulder pain (mean) | 7.48 (10.28) | 6.18 (9.96) | −1.30 (−2.38, −0.23) | 0.0179 |
Among subjects with at least 4 days/month with neck/shoulder pain at baseline | 16.7 (9.88) | 12.8 (11.39) | −3.93 (−5.99, −1.88) | 0.0003 |
Neck/shoulder pain Index (F × I) | 0.46 (0.78) | 0.39 (0.79) | −0.07 (−0.14, −0.01) | 0.0280 |
Among subjects with at least 4 days/month with neck/shoulder pain at baseline | 1.04 (0.92) | 0.84 (1.02) | −0.20 (−0.34, −0.06) | 0.0064 |
Analgesic drug consumption | ||||
Days with analgesic drug consumption (mean) | 1.67 (3.85) | 1.17 (3.44) | −0.5 (−0.93, −0.07) | 0.0222 |
Among subjects with at least 4 days/month with analgesic drug consumption at baseline | 8.56 (6.42) | 5.12 (7.53) | −3.44 (−6.01, −0.86) | 0.0111 |